{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:28:29Z","timestamp":1794860909074,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["Grant GMVCM1239P and IUT2-4"],"award-info":[{"award-number":["Grant GMVCM1239P and IUT2-4"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU European Regional Development Fund","award":["Grant 3.2.1001.11-0017"],"award-info":[{"award-number":["Grant 3.2.1001.11-0017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-016-0784-z","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:38:40Z","timestamp":1483994320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Looking beyond the brain to improve the pathogenic understanding of Parkinson\u2019s disease: implications of whole transcriptome profiling of Patients\u2019 skin"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-1852","authenticated-orcid":false,"given":"Anu","family":"Planken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lille","family":"Kurvits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ene","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liis","family":"Kadastik-Eerme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fclli","family":"Kingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulev","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pille","family":"Taba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"issue":"Suppl 3","key":"784_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord. 2009;15 Suppl 3:S1\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 3","key":"784_CR2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1353-8020(09)70770-9","volume":"15","author":"E Wolters","year":"2009","unstructured":"Wolters E. Non-motor extranigral signs and symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2009;15 Suppl 3:S6\u201312.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"784_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.22172","volume":"24","author":"R Djaldetti","year":"2009","unstructured":"Djaldetti R, Lev N, Melamed E. Lesions outside the CNS in Parkinson\u2019s disease. Movement Disorders. 2009;24(6):793\u2013800.","journal-title":"Movement Disorders"},{"issue":"1","key":"784_CR4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13311-013-0218-1","volume":"11","author":"A AlDakheel","year":"2014","unstructured":"AlDakheel A, Kalia LV, Lang AE. Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics. 2014;11(1):6\u201323.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"784_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/epr.10.40","volume":"7","author":"PA Robinson","year":"2010","unstructured":"Robinson PA. Understanding the molecular basis of Parkinson\u2019s disease, identification of biomarkers and routes to therapy. Expert Rev Proteomics. 2010;7(4):565\u201378.","journal-title":"Expert Rev Proteomics"},{"issue":"6","key":"784_CR6","first-page":"26","volume":"59","author":"JM Beitz","year":"2013","unstructured":"Beitz JM. Skin and wound issues in patients with Parkinson\u2019s disease: an overview of common disorders. Ostomy Wound Manage. 2013;59(6):26\u201336.","journal-title":"Ostomy Wound Manage"},{"issue":"1","key":"784_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler K, Ebert S, Uceyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C. Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta neuropathologica 2014;128(1):99\u2013109.","journal-title":"Acta neuropathologica"},{"issue":"18","key":"784_CR8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R. alpha-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81(18):1604\u201310.","journal-title":"Neurology"},{"issue":"2","key":"784_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.22855","volume":"25","author":"JJ Ferreira","year":"2010","unstructured":"Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C. Skin cancer and Parkinson\u2019s disease. Movement Disorders. 2010;25(2):139\u201348.","journal-title":"Movement Disorders"},{"issue":"11","key":"784_CR10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00702-009-0322-x","volume":"116","author":"R Inzelberg","year":"2009","unstructured":"Inzelberg R, Israeli-Korn SD. The particular relationship between Parkinson\u2019s disease and malignancy: a focus on skin cancers. J Neural Transm. 2009;116(11):1503\u20137.","journal-title":"J Neural Transm"},{"issue":"23","key":"784_CR11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","volume":"76","author":"R Liu","year":"2011","unstructured":"Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76(23):2002\u20139.","journal-title":"Neurology"},{"issue":"5","key":"784_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ede.0000229445.90471.5e","volume":"17","author":"JH Olsen","year":"2006","unstructured":"Olsen JH, Friis S, Frederiksen K. Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology. 2006;17(5):582\u20137.","journal-title":"Epidemiology"},{"issue":"18","key":"784_CR13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1212\/WNL.0b013e3181fb4466","volume":"75","author":"C Paisan-Ruiz","year":"2010","unstructured":"Paisan-Ruiz C, Houlden H. Common pathogenic pathways in melanoma and Parkinson disease. Neurology. 2010;75(18):1653\u20135.","journal-title":"Neurology"},{"issue":"11","key":"784_CR14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrc3150","volume":"11","author":"MJ Devine","year":"2011","unstructured":"Devine MJ, Plun-Favreau H, Wood NW. Parkinson\u2019s disease and cancer: two wars, one front. Nat Rev Cancer. 2011;11(11):812\u201323.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"784_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mehy.2008.10.011","volume":"72","author":"E Herrero Hernandez","year":"2009","unstructured":"Herrero Hernandez E. Pigmentation genes link Parkinson\u2019s disease to melanoma, opening a window on both etiologies. Med Hypotheses. 2009;72(3):280\u20134.","journal-title":"Med Hypotheses"},{"issue":"6","key":"784_CR16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9680","key":"784_CR17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet. 2009;373(9680):2055\u201366.","journal-title":"Lancet"},{"key":"784_CR18","unstructured":"Fahn S ER, UPDRS Development Committee. : Unified Parkinson\u2019s disease rating scale. Recent developments in Parkinson\u2019s disease Florham Park, NJ: Mac-Millan Healthcare Information 1987, Vol 2.:153\u2013163"},{"issue":"15","key":"784_CR19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders. 2008;23(15):2129\u201370.","journal-title":"Movement Disorders"},{"issue":"5","key":"784_CR20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology"},{"key":"784_CR21","unstructured":"Schwab RS EAIGF, Donaldson IML, eds. Third Symposium on Surgery in Parkinson\u2019s disease. Edinburgh: Livingstone, :152\u20137.: Projection technique for evaluating surgery in Parkinson\u2019s disease. In: Third Symposium on Surgery in Parkinson\u2019s disease 1969; Edinburgh: Livingstone; 1969: 152\u2013157"},{"issue":"3","key":"784_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"784_CR23","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106.","journal-title":"Genome Biol"},{"issue":"4","key":"784_CR24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","volume":"49","author":"V Ruiperez","year":"2010","unstructured":"Ruiperez V, Darios F, Davletov B. Alpha-synuclein, lipids and Parkinson's disease. Prog Lipid Res. 2010;49(4):420\u20138.","journal-title":"Prog Lipid Res"},{"issue":"Pt 21","key":"784_CR25","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","volume":"125","author":"S Austin","year":"2012","unstructured":"Austin S, St-Pierre J. PGC1alpha and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci. 2012;125(Pt 21):4963\u201371.","journal-title":"J Cell Sci"},{"issue":"52","key":"784_CR26","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med. 2010;2(52):52ra73.","journal-title":"Sci Transl Med"},{"issue":"6","key":"784_CR27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbadis.2013.12.014","volume":"1842","author":"R Parlato","year":"2014","unstructured":"Parlato R, Liss B. How Parkinson's disease meets nucleolar stress. Biochim Biophys Acta. 2014;1842(6):791\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"784_CR28","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4161\/cc.22529","volume":"11","author":"A Gandarillas","year":"2012","unstructured":"Gandarillas A. The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint. Cell Cycle. 2012;11(24):4507\u201316.","journal-title":"Cell Cycle"},{"issue":"2","key":"784_CR29","first-page":"1","volume":"5","author":"X Lim","year":"2013","unstructured":"Lim X, Nusse R. Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol 2013;5(2):1\u201325.","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:45:20Z","timestamp":1498362320000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0784-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0784-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]},"article-number":"6"}}